Consun Pharmaceutical reports active share repurchases, with 3.55m shares bought

Consun Pharmaceutical Group Limited, listed on the Hong Kong Stock Exchange, has filed its Next Day Disclosure Return detailing significant share repurchase activities between October 14 and October 31, 2025. The company repurchased a total of 3,550,000 ordinary shares for cancellation during this period, with the latest repurchase of 350,000 shares occurring on October 31, 2025, at an average price of HK$15.0258.

The repurchases were executed on the Exchange, with prices ranging from HK$14.9148 to HK$15.7565 per share. The aggregate price paid for the repurchases on October 31 alone was HK$5,259,040. The company's opening balance of issued shares (excluding treasury shares) as of October 30, 2025, was 847,973,407, remaining unchanged despite the repurchases for cancellation not yet being formally reflected.

As of October 31, 2025, the total number of shares authorized for repurchase under the mandate granted on May 22, 2025, was 85,126,334. So far, the company has repurchased 8,195,000 shares on the Exchange, representing 9.6269% of the issued shares at the time of the mandate. A moratorium period for new share issues or treasury share sales is in effect until November 30, 2025.